Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iron Isomaltoside 1000 in Patients With Iron Deficiency or Iron Deficiency Anemia: a Multicentric, Prospective, Longitudinal, Observational Study in Switzerland.

NCT04318405 is registered in ClinicalTrials.gov with Pierre Fabre Pharma AG as lead sponsor.

NCT NCT04318405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04318405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iron Isomaltoside 1000 in Patients With Iron Deficiency or Iron Deficiency Anemia: a Multicentric, Prospective, Longitudinal, Observational Study in Switzerland.
Lead sponsor
Pierre Fabre Pharma AG
Phase
Observational
Overall status
Completed
Start date
July 10, 2020
Completion date
November 30, 2022
Enrollment
327 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

iron-deficiency, iron-deficiency anemia